Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03243955
Other study ID # 441356-KH-50890
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 28, 2017
Est. completion date March 1, 2026

Study information

Verified date October 2023
Source University of California, Los Angeles
Contact Andrew Shubov, MD
Phone 310-998-9118
Email ashubov@mednet.ucla.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Transcutaneous electrical acupoint stimulation (TEAS) is an emerging technology for non-invasive neuromodulation that has broad potential implications and warrants further study. The investigators' clinical experience from the University of California, Los Angeles (UCLA) Center for East-West Medicine (CEWM) has also demonstrated that TEAS can be used as an effective self-care tool for patients with chronic illness who do not have the time or resources for frequent acupuncture treatments. Chronic constipation is the chosen area of study because of the large population with a substantial impairment in health-related quality of life and work productivity. The investigators have recently completed a randomized controlled trial (RCT) demonstrating the benefit of perineal self-acupressure on quality of life measurements in this population, which supports investigation into other acupuncture-based self-care interventions. Given these findings, the investigators hypothesize that home patient-administered TEAS can provide measurable improvements in both symptom severity and health related quality of life.


Description:

This study will be a double blinded randomized controlled trial. Respondents will be screened by phone and qualified subjects will be sent home for 2 weeks to complete a bowel movement logbook, then return into the CEWM office where they will submit validated surveys (specifically, the PAC-SYM and PAC-QOL) and have a photo taken of their tongue. A baseline non-invasive heart rate variability (HRV) measurement will be taken at this time as well. Study personnel will instruct each subject on TEAS pad placement and how to use the device, but not tell the subjects where to place the pads. The subjects will been assigned to one of two experimental groups (verum and sham) based on a 1:1 random allocation, with the study personnel blinded to the allocation. Both groups will be given transcutaneous electrical nerve stimulator (TENS) units with pre-set parameters and access to the adjustable amplitude dial for self-adjustment of amplitude, with the verum group given pre-printed information on proper application on true acupoints, and sham group will be given information on non-acupuncture points. The subjects will be instructed on daily use for 30 minutes per day for at least 5 days per week, and asked to track device use as well as bowel movement frequency and quality using a logbook. They will also submit to an online survey every week during the 4-week trial period. At the conclusion of the study, they will return the units and repeat the survey and HRV measurements.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date March 1, 2026
Est. primary completion date July 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - Satisfy a modified ROME-IV criteria for functional constipation including: - Fewer than three spontaneous bowel movements per week - and meet one of the following symptoms for at least 12 weeks in the preceding 12 months: - straining during >25% of the bowel movements (BMs) - lumpy or hard stools during >25% of BMs - sensation of incomplete evacuation during >25% of BMs - sensation of anorectal obstruction or blockage for >25% of BMs - manual maneuvers to facilitate >25% of BMs - loose stools are rarely present without the use of laxatives - insufficient criteria for IBS (does not have recurrent abdominal pain at least 1 day per week in the past 3 months) - able to understand and provide written consent - If over age 50, have undergone routine colon cancer screening (colonoscopy, sigmoidoscopy, colonography or fecal occult blood testing) - subjects must have normal serum chemistry and normal thyroid stimulating hormone (TSH) within the past year - subjects must have normal sensation over the areas where the pads will be placed (lumbar region and lower extremities surrounding the knees anteriorly) Exclusion Criteria: - Pregnancy - Numbness around the genitals or groin, bladder or bowel dysfunction or incontinence, new sciatica type leg pain or new onset sexual dysfunction within the past year. - Any changes to constipation related medications over the past 1 month - Use of rescue medication (polyethylene glycol, bisacodyl, enema, etc) greater than once per week - Pacemaker, implanted cardiac defibrillator or other implanted electrical device - 10% weight loss in past 6 months - New onset Hematochezia since last medical evaluation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Verum TEAS
TENS unit with electrodes applied to acupuncture point locations
Sham TEAS
TENS unit with electrodes applied to non-acupuncture point locations

Locations

Country Name City State
United States University of California, Los Angeles Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary spontaneous bowel movement (SBMs) per week Comparison of weekly spontaneous bowel movement (SBMs) per week between the two groups using a paired t-test comparing the final time point to the lead-in measurement. 4 weeks
Secondary Responder rate Comparison of the responder rate (responder defined as having >1 SBM per week for 2 out of the 4 treatment weeks) at the end of the study in each group 4 weeks
Secondary PAC-QOL Paired t-test will be used to compare the average PAC-QOL scores between baseline and final measurements 4 weeks
Secondary PAC-SYM Paired t-test will be used to compare the average PAC-SYM scores between baseline and final measurements 4 weeks
Secondary HRV Changes Comparison of the differences between the high frequency (HF), low frequency (LF), and LF/HF measures of the spectral analysis of HRV (heart rate variability) between the baseline and study conclusion 4 weeks
Secondary Bristol Stool Scale Comparison of the differences in the average Bristol Stool Scale between the baseline and study conclusion 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05032534 - Examination of a New Irrigation System for Transanal Irrigation in Children With Fecal Incontinence N/A
Completed NCT04587635 - Evaluation of Changes in Bowel Movement Frequency Following the Consumption of PHGG in Adults With Constipation N/A
Completed NCT03821532 - Adherence/Outcomes After Use of Constipation Action Plan N/A
Recruiting NCT06122558 - Efficacy of Probiotic Against Functional Constipation Phase 2
Recruiting NCT04086134 - Physiological, Microbiological and Metabolomic Effects of Fruit Products N/A
Recruiting NCT01587846 - Lactobacillus Reuteri in Treatment of Functional Abdominal Pain and Chronic Constipation in Children Phase 3
Recruiting NCT05496543 - Acupuncture for Functional Constipation in Older Adults N/A
Completed NCT05447481 - Evaluation of the Effect of Chicory Inulin-type Fructans in Constipated Adults N/A
Completed NCT05035784 - RCE With FMT in the Treatment of Childhood Constipation N/A
Recruiting NCT06221722 - Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
Recruiting NCT05823259 - The Impact of Respiratory Muscle Training and Patient Education on Chronic Constipation Outcomes N/A
Not yet recruiting NCT06438068 - Influence of Modern Colon Hydrotherapy on Intestinal Transit N/A
Withdrawn NCT05321953 - The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individuals With Chronic Constipation N/A
Active, not recruiting NCT05363553 - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study N/A
Recruiting NCT06031025 - Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.
Recruiting NCT05432453 - The Relationship Between Functional Constipation and Sacroiliac Joint Dysfunction
Not yet recruiting NCT05191810 - Efficacy of Educational Intervention as Supporting Element in the Treatment of Functional Constipation in Children N/A
Not yet recruiting NCT06100055 - The ReVo Study: Low-volume vs High-volume Rectal Irrigation N/A
Recruiting NCT04148248 - A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation